Glad to share our paper recently published in CCR. In which, we report distinct tumor microenvironment for the 2 molecular subtypes of adenoid cystic carcinoma. Importantly, B7-H4 is highly expressed in the poor-prognosis subtype and is a potential therapeutic target.